Market Trends Crinetics stock falls after CAH therapy data (CRNX:NASDAQ)By admin8996erT0allJanuary 10, 2025 Baris-OzerShares of Crinetics Pharmaceuticals (NASDAQ:CRNX) traded sharply lower after the company posted initial data from a Phase 2 trial for…
